This site is intended for Healthcare Professionals only.

McKesson inks pact to sell part of European business to Phoenix Group

Date:

Share post:

McKesson Corporation, parent company of LloydsPharmacy, today (July 7) signed an agreement to sell some of its European business to the German drug distributor Phoenix Group.

The agreement encompasses sale of its businesses in France, Italy, Ireland, Portugal, Belgium, and Slovenia, as McKesson looks at “strategic path” to fully exit the European region.

Last month, market talks had emerged that McKesson was trying to sell its chain of high street pharmacies as well as its pharmaceutical distributions.

The transaction is expected to complete in 2022, “subject to customary closing conditions, including receipt of required regulatory approvals,” the company said in a statement.

“Today’s transaction marks an important step in advancing McKesson’s commitment to streamline the business and prioritise investments in the areas where we have deep expertise and are central to our long-term growth strategy,” McKesson chief executive officer Brian Tyler said.

“We are confident that under the Phoenix group’s strong leadership, the businesses included in this agreement will be well-positioned for the future to compete more effectively and better serve customers,” he added.

The Phoenix group, which owns Phoenix UK and Rowlands Pharmacy, is a leading integrated healthcare provider and a leader in the European healthcare sector.

Meanwhile, McKesson will continue to operate its remaining European businesses in the UK, Norway, Austria, and Denmark, which are “not included in this transaction”, it said in a statement.

Besides, the company is committed to explore strategic alternatives for all the remaining European businesses and focus on future investments outside of Europe.

“Our goal is to accelerate our growth strategies, becoming a more focused organisation and enabling our mission to improve care in every setting,” Tyler added.

McKesson will also retain its minority equity stake in the company’s Germany joint venture with Walgreens Boots Alliance.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Europe Sees Surge in Generic Medicines Withdrawals; UK Faces Doubling of Drug Shortages

Generic medicines for cancer and mental health on the Union List of Critical Medicines are disappearing, study reveals...

NHS to support newly-trained pharmacists with new £1.5 million investment

The new initiative is set to create highly-skilled placement opportunities in community pharmacies, GP surgeries, and care homes...

Professor Mahendra Patel joins UK Pharmacy Professional Leadership Advisory Board

The nine independent expert members of the UK Pharmacy Professional Leadership Advisory Board announced   Professor Mahendra Patel OBE,...

Silent suffering: 12k NHS staff reluctant to share mental health and well-being struggles

Latest UNISON survey underscores mental health absence affecting over 30 per cent of NHS staff including paramedics, and...